How to cite item

Nivolumab as first-line treatment in non-small cell lung cancer patients—key factors: tumor mutation burden and PD-L1 ≥50%

   
@article{TLCR18439,
	author = {Paul Zarogoulidis and Vasilis Papadopoulos and Elena Maragouli and George Papatsibas and Chrysanthi Sardeli and Yan-Gao Man and Chong Bai and Haidong Huang},
	title = {Nivolumab as first-line treatment in non-small cell lung cancer patients—key factors: tumor mutation burden and PD-L1 ≥50%},
	journal = {Translational Lung Cancer Research},
	volume = {7},
	number = {Suppl 1},
	year = {2018},
	keywords = {},
	abstract = {Although we have new diagnostic equipment, lung cancer is still diagnosed at a late stage (1,2). In the past 5 years, novel targeted therapies with tyrosine kinase inhibitors based on the epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), proto-oncogene B-Raf and v-Raf murine sarcoma viral oncogene homolog B (BRAF) and proto-oncogene tyrosine-protein kinase ROS-1 (ROS-1) are used for treatment in non-small cell lung cancer (NSCLC) patients (3).},
	issn = {2226-4477},	url = {https://tlcr.amegroups.org/article/view/18439}
}